Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.39 |
| ▸ | MEN1 | O00255 | 3/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | FAAH | O00519 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1765535 | 0.95 | PPARG (0.40) | PPARGGAAKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL15230716 | 0.91 | GAA (0.38) | PPARGGAAKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL15230375 | 0.87 | PPARG (0.35) | PPARGGAAKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL15231257 | 0.87 | PPARG (0.38) | PPARGGAAKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL15230561 | 0.87 | PPARG (0.37) | PPARGGAAKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL15231208 | 0.87 | PPARG (0.37) | PPARGGAAKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL15230373 | 0.83 | GAA (0.39) | GAAKMT2AMEN1SMN1; SMN2MAPT | |
| SCHEMBL1765111 | 0.83 | PPARG (0.35) | PPARGGAAKMT2AMAPTALDH1A1 | |
| SCHEMBL1119946 | 0.83 | GAA (0.45) | PPARGGAAKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL1765165 | 0.83 | CCR1 (0.44) | PPARGGAAKMT2AMEN1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2015157005-A1 | SUBSTITUTED TOLYL FUNGICIDE MIXTURES | E I DU PONT DE NEMOURS AND COMPANY (US) | 2015-10-15 | — | — | WO | claimed |
| US-20150266850-A1 | SUBSTITUTED TOLYL FUNGICIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2015-09-24 | — | — | US | claimed |
| WO-2014130409-A2 | FUNGICIDAL PYRAZOLE MIXTURES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2014-08-28 | — | — | WO | claimed |
| US-12606548-B2 | Fungicidal oxadiazoles | FMC CORPORATION (US) | 2026-04-21 | — | — | US | disclosed |
| US-12398107-B2 | Fungicidal nitroanilino substituted pyrazoles | FMC CORPORATION (US) | 2025-08-26 | — | — | US | disclosed |
| US-20240324596-A1 | SUBSTITUTED TOLYL FUNGICIDES | FMC CORPORATION | 2024-10-03 | — | — | US | disclosed |
| EP-4388876-A2 | FUNGICIDAL NITROANILINO SUBSTITUTED PYRAZOLES | FMC Corporation (US) | 2024-06-26 | — | — | EP | disclosed |
| US-20240166638-A1 | FUNGICIDAL OXADIAZOLES | FMC CORP (US) | 2024-05-23 | — | — | US | disclosed |
| EP-3847160-B1 | FUNGICIDAL NITROANILINO SUBSTITUTED PYRAZOLES | FMC CORP (US) | 2024-05-08 | — | — | EP | disclosed |
| EP-3558984-B1 | FUNGICIDAL OXADIAZOLES | FMC CORP (US) | 2023-08-02 | — | — | EP | disclosed |
| US-11708358-B2 | Fungicidal oxadiazoles | FMC CORPORATION (US) | 2023-07-25 | — | — | US | disclosed |
| EP-2912020-A1 | SUBSTITUTED TOLYL FUNGICIDES | E. I. du Pont de Nemours and Company (US) | 2015-09-02 | — | — | EP | disclosed |
| WO-2015123193-A1 | FUNGICIDAL BENZODIPYRAZOLES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2015-08-20 | — | — | WO | disclosed |
| EP-2809157-A2 | FUNGICIDAL PYRAZOLE MIXTURES | E. I. Du Pont de Nemours and Company (US) | 2014-12-10 | — | — | EP | disclosed |
| WO-2014172191-A1 | FUNGICIDAL CARBOXAMIDES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2014-10-23 | — | — | WO | disclosed |
| WO-2014172190-A1 | FUNGICIDAL AMIDES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2014-10-23 | — | — | WO | disclosed |
| WO-2014130409-A2 | FUNGICIDAL PYRAZOLE MIXTURES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2014-08-28 | — | — | WO | disclosed |
| WO-2014066120-A1 | SUBSTITUTED TOLYL FUNGICIDES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2014-05-01 | — | — | WO | disclosed |
| WO-2013116251-A2 | FUNGICIDAL PYRAZOLE MIXTURES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2013-08-08 | — | — | WO | disclosed |
| US-20110124501-A1 | Active compound combinations | BAYER CROPSCIENCE AG (DE) | 2011-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110124501-A1 | Active compound combinations | CYP51A1, CA4, BROX | PPARG 402/4885GAA 90/4885KMT2A 3240/4885 |
| US-20150266850-A1 | SUBSTITUTED TOLYL FUNGICIDES | TH, CYP1B1, CYP1A1 | PPARG 4369/4885GAA 369/4885KMT2A 3392/4885 |
| US-20240166638-A1 | FUNGICIDAL OXADIAZOLES | OXA1L, NOX1, TH | PPARG 4551/4885GAA 516/4885KMT2A 4094/4885 |
| US-20240324596-A1 | SUBSTITUTED TOLYL FUNGICIDES | TH, NAT1, CYP1B1 | PPARG 4299/4885GAA 500/4885KMT2A 3653/4885 |
| US-12398107-B2 | Fungicidal nitroanilino substituted pyrazoles | TH, NOX1, NOX3 | PPARG 4264/4885GAA 1484/4885KMT2A 3322/4885 |
| US-12606548-B2 | Fungicidal oxadiazoles | AOC2, AOC3, MT-CO3 | PPARG 4789/4885GAA 2552/4885KMT2A 2992/4885 |
| US-11708358-B2 | Fungicidal oxadiazoles | OXA1L, NOX1, TH | PPARG 4551/4885GAA 516/4885KMT2A 4094/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.